Study highlights barriers to breast cancer screening for Black women in the UK

As the year is near­ing a close, law­mak­ers are still chip­ping away at spend­ing bills and a long to-do list of health pol­i­cy pri­or­i­ties that

Sanofi wasn’t the on­ly par­ty in­ter­est­ed in Te­va’s an­ti-TL1A an­ti­body, but it emerged as the “per­fect part­ner” to se­cure a deal worth up to $1.5